Youfeng Yang
Impact in
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
- Aging top 2%
Papers in
-
- Renal cell carcinoma treatment 25
-
- Cancer Genomics and Diagnostics 7
- Cancer, Hypoxia, and Metabolism 7
- Co-authors
- William Marston Linehan (35 shared papers)Navdeep S. Chandel (1 shared paper)Tzuling Cheng (1 shared paper)Lucas B. Sullivan (1 shared paper)Andrew R. Mullen (1 shared paper)Ralph J. DeBerardinis (1 shared paper)Pei-Hsuan Chen (1 shared paper)Eunsook S. Jin (1 shared paper)
- Journals
- Genes Chromosomes and Cancer (5 papers)The Journal of Urology (4 papers)PLoS ONE (3 papers)Oncotarget (3 papers)JNCI Journal of the National Cancer Institute (2 papers)
- Partner nations
- United StatesChinaJapan
In The Last Decade
Youfeng Yang
62 papers receiving 4.3k citations
Youfeng Yang's Hit Papers
Peers
Comparison fields: 5 of 107
- Cancer Research 1.6k
- Aging 123
- Pulmonary and Respiratory Medicine 1.3k
- Molecular Biology 2.7k
- Biochemistry 141
Countries citing papers authored by Youfeng Yang
This map shows the geographic impact of Youfeng Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youfeng Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youfeng Yang more than expected).
Fields of papers citing papers by Youfeng Yang
This network shows the impact of papers produced by Youfeng Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youfeng Yang. The network helps show where Youfeng Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Youfeng Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Reductive carboxylation supports growth in tumour cells with defective mitochondria Hit paper breakdown → | 2011 | 1126 |
| 2 | 2014 | 252 | |
| 3 | 2012 | 200 | |
| 4 | 2005 | 192 | |
| 5 | 2008 | 192 | |
| 6 | 2009 | 192 | |
| 7 | 2011 | 189 | |
| 8 | The RASSF1A tumor suppressor gene is inactivated in prostate tumors and suppresses growth of prostate carcinoma cells. | 2002 | 139 |
| 9 | 2009 | 128 | |
| 10 | 2010 | 103 | |
| 11 | 2015 | 100 | |
| 12 | 2014 | 93 | |
| 13 | 2013 | 93 | |
| 14 | 2012 | 92 | |
| 15 | 2015 | 81 | |
| 16 | 2010 | 75 | |
| 17 | 2017 | 73 | |
| 18 | 2021 | 73 | |
| 19 | 2012 | 63 | |
| 20 | 2012 | 54 |
About Youfeng Yang
Youfeng Yang is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology, Aging and Endocrine and Autonomic Systems, having authored 64 papers that have together received 4.4k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (25 papers), Renal and related cancers (20 papers), Cancer Genomics and Diagnostics (7 papers), Cancer, Hypoxia, and Metabolism (7 papers), Epigenetics and DNA Methylation (4 papers), Genetics, Aging, and Longevity in Model Organisms (4 papers), Ubiquitin and proteasome pathways (3 papers) and Mitochondrial Function and Pathology (2 papers). The work is most often cited by research in Cancer Research (1.6k citations), Aging (123 citations), Pulmonary and Respiratory Medicine (1.3k citations), Molecular Biology (2.7k citations) and Biochemistry (141 citations). Youfeng Yang has collaborated with scholars based in United States, China and Japan. Frequent co-authors include William Marston Linehan, Navdeep S. Chandel, Tzuling Cheng, Lucas B. Sullivan, Andrew R. Mullen, Ralph J. DeBerardinis, Pei-Hsuan Chen, Eunsook S. Jin, William W. Wheaton and María José Beato Merino. Their work appears in journals such as Genes Chromosomes and Cancer, The Journal of Urology, PLoS ONE, Oncotarget and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.